Adopting New Approaches in AL Amyloidosis: Expert Perspectives on Latest Evidence

Download slides read an expert commentary and view an on-demand webcast from a live webinar on evolving practices in managing newly diagnosed and relapsed light-chain amyloidosis.

Share

Program Content

No activities added yet

Activities

Amyloidosis: Diagnosis
Amyloidosis: Classification, Diagnosis, Staging, and Response Assessment
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 18, 2022

Expires: January 17, 2023

Amyloidosis Management
Initial Management of Light-chain Amyloidosis
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 18, 2022

Expires: January 17, 2023

Amyloidosis at Relapse
Management of Light-chain Amyloidosis at Relapse
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 18, 2022

Expires: January 17, 2023

<i>EP</i>: AL Amyloidosis
ExpressPoints:
Adopting New Approaches in AL Amyloidosis: Expert Perspectives on Latest Evidence
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 19, 2022

Expires: January 18, 2023

Activities

AL Amyloidosis
Managing Light-Chain Amyloidosis: Experts Respond to Your Questions on Optimizing Care
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 09, 2022

Expires: February 08, 2023

Faculty

cover img faculity

Ankit Kansagra, MD

Eugene P. Frenkel MD Scholar of Clinical Medicine
Assistant Professor of Medicine
Division of Hematology/Oncology
University Texas Southwestern Medical Center
Dallas, Texas

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Mayo Clinic
Rochester, Minnesota

cover img faculity

Vaishali Sanchorawala, MD

Professor of Medicine
Director, Amyloidosis Center
Boston University School of Medicine
Director, Autologous Stem Cell Transplantation Program
Section of Hematology-Oncology
Boston Medical Center
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Janssen administered by Scientific Affairs